Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-061590

SVP & Chief Medical Officer returned 5,022 shares (to the company)

  • SVP & Chief Medical Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gergel Ivan P. · SVP & Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-15 Grant or award : show line 1 in the form +20,000 61,575 D
2017-11-16 Returned to the company : show line 2 in the form −5,022 $44.23 $222,123 56,553 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-11-15 Grant or award : show line 3 in the form Stock Option +50,000 50,000 D
Loading xslF345X03/doc4.xml…